OrthoPediatrics counsel gets stock grant, sells shares

OrthoPediatrics Corp General Counsel Daniel J. Gerritzen reported compensation-related stock activity.

Rhea-AI Filing Summary

OrthoPediatrics Corp General Counsel Daniel J. Gerritzen reported compensation-related stock activity. On March 15, he acquired 47,380 shares of common stock as a grant or award at $0.00 per share. On March 16, he sold 8,614 shares at $17.25 per share.

According to a footnote, the shares sold on March 16 were used to satisfy tax-withholding obligations tied to the vesting of restricted shares, rather than a discretionary sale. After these transactions, he directly holds 149,533 shares of common stock, which includes restricted stock awards totaling 121,054 shares.

Insider Trade Summary

Net Seller: 8,614 shares

Net Sell 2 txns

Insider Gerritzen Daniel J

Role General Counsel and Secretary

Sold 8,614 shs ($149K)

Type	Security	Shares	Price	Value
Sale	Common Stock	8,614	$17.25	$149K
Grant/Award	Common Stock	47,380	$0.00	$0.00

Holdings After Transaction: Common Stock — 149,533 shares (Direct)

Footnotes (2)

1. F1. Shares sold to satisfy tax withholding obligations upon vesting of restricted shares.
2. F2. Includes restricted stock awards totaling 121,054 shares.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did OrthoPediatrics (KIDS) General Counsel report?

Daniel J. Gerritzen reported a stock grant and a related sale. He received 47,380 common shares as a grant on March 15 and sold 8,614 shares at $17.25 on March 16 to cover tax obligations.

Why did Daniel J. Gerritzen sell 8,614 OrthoPediatrics (KIDS) shares?

The 8,614 shares were sold to satisfy tax withholding obligations upon the vesting of restricted shares. This indicates a mechanistic, tax-driven sale rather than a discretionary decision to reduce his economic exposure to OrthoPediatrics stock.

How many OrthoPediatrics (KIDS) shares does Daniel J. Gerritzen now hold?

Following the reported transactions, Daniel J. Gerritzen directly holds 149,533 shares of OrthoPediatrics common stock. A filing footnote specifies that this amount includes 121,054 shares of restricted stock awards that remain subject to vesting conditions.

What type of stock award did OrthoPediatrics (KIDS) grant to its General Counsel?

He received a grant or award of 47,380 shares of common stock on March 15 at $0.00 per share. This reflects equity-based compensation rather than an open-market purchase funded with personal cash.

Is the OrthoPediatrics (KIDS) insider sale part of routine tax withholding?

Yes. A footnote states the 8,614 shares sold on March 16 were used to satisfy tax withholding obligations from restricted share vesting, suggesting a routine, compensation-related transaction instead of a discretionary sale driven by market views.

Does Daniel J. Gerritzen still have significant equity exposure to OrthoPediatrics (KIDS)?

He continues to hold 149,533 common shares directly, including 121,054 restricted shares. This indicates a substantial ongoing equity stake tied to both current ownership and the future vesting of stock-based compensation awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 04:18 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gerritzen Daniel J

(Last) (First) (Middle)

C/O ORTHOPEDIATRICS CORP.

2850 FRONTIER DRIVE

(Street)

WARSAW IN 46582

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ORTHOPEDIATRICS CORP [ KIDS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel and Secretary

3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/15/2026		A		47,380	A	$0	158,147	D
Common Stock	03/16/2026		S		8,614(1)	D	$17.25	149,533(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares sold to satisfy tax withholding obligations upon vesting of restricted shares.

2. Includes restricted stock awards totaling 121,054 shares.

Remarks:

	/s/ Daniel J. Gerritzen, Attorney-in-Fact	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.